Goldman Sachs downgraded Icon (ICLR) to Neutral from Buy with a price target of $200, down from $250. While the firm continues to believe that ...

Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $136.00.

March 20 (Reuters) - Goldman Sachs downgraded its recommendation on South African equities to "marketweight" from "overweight" on Thursday, saying the European Union's growth prospects presented ...

A nearly 10% fall in the S&P 500 (^GSPC) has prompted Wall Street strategists to revaluate their bullish views headed into ...

The Apple Card is a no-fee credit card with an impressive lineup of benefits and rewards. Here's everything you need to know.

Goldman Sachs Asset Management is launching its first biodiversity fund for bond investors, in a move it says provides a new product to a market that’s so far been dominated by other asset classes.

March 12 (Reuters) - Goldman Sachs has trimmed its 2025-end target for the S&P 500 Index (.SPX), opens new tab to 6,200 from 6,500, citing increased policy uncertainty, particularly on tariffs ...

It's a big options expiry day, with $2.7 trillion worth of contracts set to expire, per Goldman Sachs. Some $1.2 trillion of that is just on contracts tied to the S&P 500. There's also $615 ...

That’s according to Goldman Sachs strategists, who on Monday bumped their target on China’s CSI 300 index XX:000300, up 0.3% so far this year, to 4,700 from 4,600, which they say implies a 19% ...